Phage Therapy’s Latest Makeover
As issues of product consistency, standardization and specificity are being tackled, can phage therapeutics—long oversold and overhyped—finally realize their antibacterial potential?
Archives
The Virome Hunters
Ambitious efforts to catalog viruses across the globe may facilitate our understanding of viral communities and ecology, boost infectious disease diagnostics and surveillance, and spur new therapeutics.
Many Pediatric Studies Are a Waste of Time
New initiatives aim to lessen the obstacles to finding useful treatments for children
First Deuterated Drug Approved
In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.
Children With Cancer Get More Access to Experimental Drugs
New U.S. law will require pediatric cancer clinic trials.
U.S. Preventive Services Task Force Confronts Critics
In May, the U.S. Preventive Services Task Force recommended against screening for thyroid cancer. After reviewing the available evidence, the task force concluded…